We are live on
!
Find out more
Brown Advisory Portfolio holdings
AUM
$60.9B
1-Year Est. Return
15.24%
This Fund
S&P 500
This Quarter
Est. Return
+9.9%
1 Year Est. Return
+15.24%
3 Year Est. Return
+71.23%
5 Year Est. Return
+86.65%
10 Year Est. Return
+447.92%
AUM
$30.8B
AUM Growth
+$2.83B
(+10%)
Cap. Flow
+$314M
Cap. Flow
% of AUM
1.02%
Top 10 Holdings %
Top 10 Hldgs %
29.43%
Holding
995
New
101
Increased
392
Reduced
278
Closed
51
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$434M |
| 2 |
Estee Lauder
EL
|
+$90.8M |
| 3 |
Visa
V
|
+$90M |
| 4 |
Amphenol
APH
|
+$67.6M |
| 5 |
ESRX
Express Scripts Holding Company
ESRX
|
+$57.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Idexx Laboratories
IDXX
|
+$409M |
| 2 |
CTXS
Citrix Systems Inc
CTXS
|
+$322M |
| 3 |
Apple
AAPL
|
+$115M |
| 4 |
TotalEnergies
TTE
|
+$31.5M |
| 5 |
Deckers Outdoor
DECK
|
+$27.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.08% |
| 2 | Healthcare | 15.56% |
| 3 | Financials | 11.89% |
| 4 | Industrials | 9.57% |
| 5 | Energy | 9.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EXFO
276
DELISTED
EXFO INC.
EXFO
| $7.5M | 0.02% |
1,576,090
-15,565
| -1% | -$81.1K |
|
277
Team
TISI
$77.7M
| $7.48M | 0.02% |
+17,672
| New | +$6.81M |
|
278
Casey's General Stores
CASY
$31.9B
| $7.41M | 0.02% |
105,413
+6,495
| +7% | +$475K |
|
279
Delta Air Lines
DAL
$55.9B
| $7.34M | 0.02% |
267,370
-50,000
| -16% | -$1.34M |
|
280
UnitedHealth
UNH
$382B
| $7.28M | 0.02% |
96,613
+3,511
| +4% | +$252K |
|
281
Cato Corp
CATO
$65.9M
| $7.16M | 0.02% |
225,138
+12,427
| +6% | +$382K |
|
|
CERN
282
DELISTED
Cerner Corp
CERN
| $7.15M | 0.02% |
128,287
-1,484
| -1% | -$83.2K |
|
283
GameStop
GME
$9.5B
| $7.13M | 0.02% |
578,708
-46,104
| -7% | -$591K |
|
284
Harley-Davidson
HOG
$2.68B
| $7.07M | 0.02% |
102,150
| – | – |
|
|
GFIG
285
DELISTED
GFI GROUP INC
GFIG
| $6.91M | 0.02% |
1,767,607
+106,526
| +6% | +$387K |
|
286
Donaldson
DCI
$10.8B
| $6.91M | 0.02% |
158,952
+4,785
| +3% | +$195K |
|
287
Air Products & Chemicals
APD
$66.3B
| $6.75M | 0.02% |
65,313
-1,561
| -2% | -$157K |
|
288
HSBC
HSBC
$355B
| $6.41M | 0.02% |
134,946
-2,317
| -2% | -$110K |
|
289
McCormick & Company Non-Voting
MKC
$13.4B
| $6.39M | 0.02% |
185,524
+2,660
| +1% | +$90.8K |
|
|
AGN
290
DELISTED
Allergan Inc
AGN
| $6.36M | 0.02% |
57,286
-6,674
| -10% | -$638K |
|
|
RDS.A
291
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $6.33M | 0.02% |
88,765
-2,024
| -2% | -$136K |
|
292
Omnicom Group
OMC
$22.7B
| $6.18M | 0.02% |
83,158
+3,457
| +4% | +$238K |
|
293
Capitol Federal Financial
CFFN
$1.08B
| $6.18M | 0.02% |
510,029
+31,475
| +7% | +$389K |
|
294
Caterpillar
CAT
$409B
| $6.17M | 0.02% |
67,911
-802
| -1% | -$68.5K |
|
|
WIFI
295
DELISTED
Boingo Wireless, Inc.
WIFI
| $6.15M | 0.02% |
958,981
+54,368
| +6% | +$362K |
|
296
iShares MSCI Emerging Markets ETF
EEM
$28B
| $6.13M | 0.02% |
146,780
+877
| +0.6% | +$36.7K |
|
|
WIN
297
DELISTED
Windstream Holdings Inc
WIN
| $6.12M | 0.02% |
97,906
-2,785
| -3% | -$180K |
|
298
Becton Dickinson
BDX
$43.1B
| $6.1M | 0.02% |
56,570
+750
| +1% | +$77.8K |
|
299
Middleby
MIDD
$6.05B
| $6.08M | 0.02% |
76,053
-417
| -0.5% | -$30.9K |
|
300
Vishay Precision Group
VPG
$1.39B
| $6.05M | 0.02% |
406,668
+1,853
| +0.5% | +$28.4K |
|
Similar funds
QCM
Brown Advisory's Q4 2013 Portfolio in Review
As of Q4 2013, Brown Advisory held 995 positions worth $30.8B, up 10% from $28B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Brown Advisory's Q4 2013 filing shows 101 new, 392 increased, 278 reduced and 51 closed positions. Its largest new stake was Plains GP Holdings: 157,910 shares worth $11.3M. The largest sale was Idexx Laboratories, an estimated $409M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.
- Brown Advisory's largest Q4 2013 buy was Plains GP Holdings: 157,910 shares worth $11.3M.
- Brown Advisory added most to Gilead Sciences in Q4 2013, an estimated $434M increase.
- Brown Advisory's biggest Q4 2013 reduction was Idexx Laboratories, cutting an estimated $409M.
- Brown Advisory fully exited Ariad Pharmaceuticals Inc in Q4 2013, selling an estimated $19.5M.
- Brown Advisory's ten largest holdings make up 29% of its $30.8B portfolio in Q4 2013.
- Brown Advisory opened 101 new positions and closed 51 in Q4 2013.
- Brown Advisory's portfolio value rose 10% quarter-over-quarter to $30.8B.
Based on Brown Advisory's 13F filing for Q4 2013, filed 11 Feb 2014.